Tate & Lyle (LON:BD15) has been assigned a GBX 670 ($9.39) price target by research analysts at Credit Suisse Group in a research note issued on Thursday. The brokerage presently has a “neutral” rating on the stock.
Other analysts have also recently issued research reports about the company. Kepler Capital Markets set a GBX 660 ($9.25) price target on Tate & Lyle and gave the company a “neutral” rating in a report on Friday, October 27th. Goldman Sachs Group set a GBX 660 ($9.25) price target on Tate & Lyle and gave the company a “neutral” rating in a report on Friday, November 3rd. Finally, Jefferies Group set a GBX 750 ($10.52) price target on Tate & Lyle and gave the company a “buy” rating in a report on Monday, October 23rd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of GBX 708.75 ($9.94).
Shares of Tate & Lyle (LON:BD15) opened at GBX 111.50 ($1.56) on Thursday. The stock has a market capitalization of $3,040.00 and a PE ratio of 210.38. Tate & Lyle has a 1-year low of GBX 102 ($1.43) and a 1-year high of GBX 116 ($1.63).
Tate & Lyle Company Profile
Tate & Lyle PLC is a provider of ingredients and solutions to the food, beverage and other industries. The Company’s segments include Speciality Food Ingredients and Bulk Ingredients. The Speciality Food Ingredients segment’s product categories include dairy, beverage, bakery and convenience. The Bulk Ingredients segment’s product lines include bulk sweeteners for food and beverage customers, and industrial starches for paper and construction industries.
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.